Patents by Inventor Daniel Anton de Boer

Daniel Anton de Boer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for increasing the activity of a cystic fibrosis transmembrane conductance regulator protein
    Patent number: 9994856
    Abstract: The present invention relates to the field of gene therapy, more specifically to oligonucleotides for making a change in the sequence of a target RNA molecule present in a living cell.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: June 12, 2018
    Assignee: ProQR Therapeutics II B.V.
    Inventors: Daniel Anton De Boer, Tita Ritsema
  • OLIGONUCLEOTIDES FOR MAKING A CHANGE IN THE SEQUENCE OF A TARGET RNA MOLECULE PRESENT IN A LIVING CELL
    Publication number: 20170152518
    Abstract: The present invention relates to the field of gene therapy, more specifically to oligonucleotides for making a change in the sequence of a target RNA molecule present in a living cell
    Type: Application
    Filed: February 10, 2017
    Publication date: June 1, 2017
    Inventors: Daniel Anton De Boer, Tita Ritsema
  • Oligonucleotides for making a change in the sequence of a target RNA molecule present in a living cell
    Patent number: 9605255
    Abstract: The present invention relates to the field of gene therapy, more specifically to oligonucleotides for making a change in the sequence of a target RNA molecule present in a living cell.
    Type: Grant
    Filed: July 12, 2013
    Date of Patent: March 28, 2017
    Assignee: ProQR Therapeutics II B.V.
    Inventors: Daniel Anton De Boer, Tita Ritsema
  • EXON REPLACEMENT WITH STABILIZED ARTIFICIAL RNAS
    Publication number: 20150209448
    Abstract: The present invention relates to the field of gene therapy, more specifically to the use of stabilized artificial RNA molecules for trans-splicing reactions to replace faulty exons for healthy exons. The present invention further relates to the use of the stabilized RNA molecules for treatment of genetic diseases.
    Type: Application
    Filed: July 12, 2013
    Publication date: July 30, 2015
    Inventors: Daniel Anton de Boer, Tita Ritsema
  • OLIGONUCLEOTIDES FOR MAKING A CHANGE IN THE SEQUENCE OF A TARGET RNA MOLECULE PRESENT IN A LIVING CELL
    Publication number: 20150197744
    Abstract: The present invention relates to the field of gene therapy, more specifically to oligonucleotides for making a change in the sequence of a target RNA molecule present in a living cell
    Type: Application
    Filed: July 12, 2013
    Publication date: July 16, 2015
    Inventors: Daniel Anton de Boer, Tita Ritsema